![Klaus Jensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Presently, Klaus Henning Jensen is Chief Medical Officer for Vifor Pharma AG. In the past Dr. Jensen occupied the position of Therapeutic Area Head & Diabetes Development at Sanofi. Dr. Jensen received a doctorate from the University of Copenhagen and an MBA from Copenhagen Business School.
Former positions of Klaus Jensen
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 2019-11-30 |
| NOVO NORDISK A/S | General Counsel | - |
| VIFOR PHARMA | Chief Tech/Sci/R&D Officer | - |
Training of Klaus Jensen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Klaus Jensen
